Insider trade

Officer sold ~$209K of BDX shares in the open market

Traded Jan 15, 2026 · Filed Jan 16, 2026

Becton DickinsonBDX

~$209K
Reported value · 1,010 sh @ $206.54: 12K
Holds after · shares reported: -14.5%
stock since the trade · S&P 500 +10.4%, $208.35 → $178.07 on Oct 1

Why it stands out

Becton Dickinson's & Pres Med.Essntl&BioPharm sold $209K of Becton Dickinson shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 15, 2026
Reporting period: Not applicable
Filed with the SEC: Jan 16, 2026

Officer$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$208,605

Shares × reported transaction price

Timing vs results

70 days after results of Nov 6, 2025, 25 days before results of Feb 9, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $208.35 on Jan 15, 2026, 26% above its 52-week low and 16% below its high, after a 9% rise over the previous 30 trading days

52-week range $165.15 (May 6, 2025) to $249.08 (Jan 28, 2025), 51% of the way up, from 251 adjusted closes. 30 trading days earlier: $190.47 on Dec 2, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	0.0%	+2.6%	-2.6%
30 days	-10.3%	+1.0%	-11.3%
90 days	-22.0%	+4.6%	-26.6%
180 days	-24.1%	+9.5%	-33.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0001944816-26-000002
Filed / recorded: Jan 16, 2026, 8:43 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BECTON DICKINSON & CO
Issuer CIK: 10795
Ticker: BDX
Reporting person: Michael David Garrison
Relationship: Officer
Officer title: EVP & Pres Med.Essntl&BioPharm
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jan 15, 2026
Transaction code: S
Shares / units: 1,010
Price per share: $206.54
Acquired / disposed: Disposed (D)
Shares owned after: 12,095
Ownership form: Direct
Amendment: No

Around the same time

8mo ago

100Derivative units · @ $201.91

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

8mo ago

30Derivative units · @ $201.91

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

8mo ago

272Derivative units · @ $201.91

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record